Arca
Skip to content
Tools
Tools

Bifunctional dihydrofolate reductase-thymidylate synthase

Protein in Plasmodium falciparum K1 that 3 drugs act on.

  • Drugs that act on it: 3
  • Approved: 2
  • In phases 1 to 3: 1
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3

Approved2

  • Pyrimethamine
  • Proguanil

Phase 30

    Phase 21

    • Cycloguanil

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Dihydrofolate reductase inhibitor.
      PyrimethamineApprovedTilde SciencesSmall moleculeInhibitor9
      ProguanilApprovedPfizerSmall moleculeInhibitor0
      CycloguanilPhase 2—Small moleculeInhibitor0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
      Combining Latency Reversing Agents to Address the HIV ReservoirPyrimethaminePhase 1 / Phase 2Not yet recruitingErasmus Medical CenterFeb 3, 2026
      Perennial Malaria Chemoprevention in the Malaria Vaccine EraPyrimethaminePhase 4Not yet recruitingStanford UniversityJan 7, 2026
      Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute MalnutritionPyrimethamineNot applicableActive, not recruitingWashington University School of MedicineMar 11, 2025
      Perennial Malaria Chemoprevention (PMC) Effect StudyPyrimethamineNot applicableActive, not recruitingMalaria ConsortiumDec 4, 2023
      Improving Cognition and Gestational Duration With Targeted NutritionPyrimethamineNot applicableActive, not recruitingWashington University School of MedicineJul 17, 2023
      Community-based, Controlled, Open-label, Cluster-randomized Trial for the Reduction of Chronic Malnutrition in Children Under Two Years of Age, With Three Intervention Arms Grouped by Clusters, in Two Provinces in Southern Angola, Huíla and Cunene.PyrimethamineNot applicableActive, not recruitingHospital Universitari Vall d'Hebron Research InstituteOct 7, 2022
      Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in PregnancyPyrimethaminePhase 3Active, not recruitingMenzies School of Health ResearchJun 22, 2022
      Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm BirthPyrimethaminePhase 3Active, not recruitingTampere UniversityAug 17, 2005

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1939, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.